Al-Moujahed Ahmad, Velez Gabriel, Vu Jennifer T, Lima de Carvalho Jose R, Levi Sarah R, Bassuk Alexander G, Sepah Yasir J, Tsang Stephen H, Mahajan Vinit B
Molecular Surgery Laboratory, Stanford University, Palo Alto, CA.
Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA.
Ophthalmol Sci. 2022 Jun;2(2). doi: 10.1016/j.xops.2022.100131. Epub 2022 Feb 24.
To identify vitreous molecular biomarkers associated with autoimmune retinopathy (AIR).
Case-control study.
We analyzed six eyes from four patients diagnosed with AIR and eight comparative controls diagnosed with idiopathic macular holes and epiretinal membranes.
Vitreous biopsies were collected from the participants and analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS) or multiplex ELISA.
Protein expression changes were evaluated by 1-way ANOVA (significant p-value <0.05), hierarchical clustering, and pathway analysis to identify candidate protein biomarkers.
There were 16 significantly upregulated and 17 significantly downregulated proteins in the vitreous of three AIR patients compared to controls. The most significantly upregulated proteins included lysozyme C (LYSC), zinc-alpha-2-glycoprotein (ZA2G), complement factor D (CFAD), transforming growth factor-beta induced protein (BGH3), beta-crystallin B2, and alpha-crystallin A chain. The most significantly downregulated proteins included disco-interacting protein 2 homolog (DIP2C), retbindin (RTBDN), and amyloid beta precursor like protein 2 (APLP2). Pathway analysis revealed that vascular endothelial growth factor (VEGF) signaling was a top represented pathway in the vitreous of AIR patients compared to controls. In comparison to a different cohort of three AIR patients analyzed by multiplex ELISA, a commonly differentially expressed protein was neuronal cell adhesion molecule (NrCAM) with p-values of 0.027 in the LC-MS/MS dataset and 0.035 in the ELISA dataset.
Protein biomarkers such as NrCAM in the vitreous may eventually help diagnose AIR.
鉴定与自身免疫性视网膜病变(AIR)相关的玻璃体分子生物标志物。
病例对照研究。
我们分析了4例诊断为AIR的患者的6只眼,以及8例诊断为特发性黄斑裂孔和视网膜前膜的对照者。
从参与者中采集玻璃体活检样本,并使用液相色谱 - 串联质谱法(LC-MS/MS)或多重ELISA进行分析。
通过单因素方差分析(显著p值<0.05)、层次聚类和通路分析评估蛋白质表达变化,以鉴定候选蛋白质生物标志物。
与对照组相比,3例AIR患者的玻璃体中有16种蛋白质显著上调,17种蛋白质显著下调。上调最显著的蛋白质包括溶菌酶C(LYSC)、锌α-2-糖蛋白(ZA2G)、补体因子D(CFAD)、转化生长因子-β诱导蛋白(BGH3)、β-晶状体蛋白B2和α-晶状体蛋白A链。下调最显著的蛋白质包括盘状相互作用蛋白2同源物(DIP2C)、视黄醛结合蛋白(RTBDN)和淀粉样β前体样蛋白2(APLP2)。通路分析显示,与对照组相比,血管内皮生长因子(VEGF)信号通路是AIR患者玻璃体中最具代表性的通路。与通过多重ELISA分析的另一组3例AIR患者相比,一种共同差异表达的蛋白质是神经元细胞粘附分子(NrCAM),在LC-MS/MS数据集中p值为0.027,在ELISA数据集中p值为0.035。
玻璃体中的蛋白质生物标志物如NrCAM最终可能有助于诊断AIR。